Cardinal Health, Inc.      (NYSE: CAH)

Cardinal Health, Inc. provides products and services to the healthcare industry.  The company's Healthcare Supply Chain Services-Pharmaceutical segment distributes various branded and generic pharmaceutical products, and over-the-counter products to retail customers, hospitals, and alternate care providers in the United States; offers distribution services, inventory management services, data/reporting services, new product launch support, and contract and chargeback administration services to pharmaceutical manufacturers; provides third-party logistics support services; distributes therapeutic plasma to hospitals and clinics in the United States; manufactures and markets generic pharmaceuticals for sale to hospitals, clinics and pharmacies in the United Kingdom; operates a specialty pharmacy; and operates as a franchisor of apothecary-style retail pharmacies.  Its Healthcare Supply Chain Services-Medical segment distributes various branded and private-label medical and laboratory products to hospitals, laboratories, and ambulatory care customers in the United States and Canada.  The company's Clinical Technologies and Services segment develops, manufactures, leases and sells medical technology products, including Alaris intravenous medication safety and infusion therapy delivery systems, software applications, needle-free disposables, and related patient monitoring equipment, and Pyxis dispensing systems.  The segment also offers pharmacy services and clinical intelligence solutions.  Its Medical Products Manufacturing segment develops and manufactures medical and surgical products, including infection prevention products and medical specialties products for distribution to hospitals, physician offices, surgery centers, and other healthcare providers.  Cardinal Health was founded in 1979 as Cardinal Distribution, Inc. and changed its name in July 1994.  Cardinal Health is headquartered in Dublin, Ohio.